Yang Luke Chen Sells 44,000 Shares of 111 (NASDAQ:YI) Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 44,000 shares of the firm’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $0.23, for a total transaction of $10,120.00. Following the completion of the sale, the director owned 495,462 shares of the company’s stock, valued at $113,956.26. This trade represents a 8.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Friday, June 12th, Yang Luke Chen sold 49,920 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $11,481.60.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The shares were sold at an average price of $0.25, for a total transaction of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $388.80.

111 Trading Down 0.9%

Shares of YI opened at $4.41 on Thursday. The stock has a market cap of $38.76 million, a P/E ratio of -3.15 and a beta of 0.60. The company has a 50-day moving average of $5.80 and a two-hundred day moving average of $5.67. 111, Inc. Sponsored ADR has a 12-month low of $2.48 and a 12-month high of $11.17.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.